Free Trial
LON:PCGH

Polar Capital Glb Healthcare Interim Earnings Report

GBX 400 -3.00 (-0.74%)
As of 06/3/2026 12:30 PM Eastern

Polar Capital Glb Healthcare EPS Results

Actual EPS
GBX 0.46
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Polar Capital Glb Healthcare Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Polar Capital Glb Healthcare Announcement Details

Quarter
Interim
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Polar Capital Glb Healthcare Earnings Headlines

Musk's shopping list: batteries ✓ solar ✓ data ✓ power ___
Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity for $2.6 billion and Twitter for $44 billion. Now one small company makes the equipment his Colossus supercomputer - a million GPUs consuming nearly $1 billion a month in power - cannot run without. Analyst Dylan Jovine has identified the name and ticker. For investors who own shares before a potential move, the math could be significant.tc pixel
PLCQD Polar Capital Technology Trust plc
See More Polar Capital Glb Healthcare Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Polar Capital Glb Healthcare? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Polar Capital Glb Healthcare and other key companies, straight to your email.

About Polar Capital Glb Healthcare

Polar Capital Global Healthcare Trust plc (PCGH) made its debut on the London Stock Exchange in June 2010, raising £89m from a wide selection of investors. The Trust was launched as an opportunity to invest in the long-term growth appeal of the global healthcare sector, with a focus on large companies, particularly global pharmaceutical stocks. PCGH was a more cautious way to invest in the sector, with the Trust holding at least 80% in large, established companies and the freedom to invest across all subsectors globally. Up to 20% could be allocated to smaller, growth companies offering a higher risk/return profile. The subsectors the Trust looks at include healthcare services and healthcare technology, pharmaceuticals, healthcare equipment, biotechnology, life sciences tools and managed healthcare.

View Polar Capital Glb Healthcare Profile